Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Behçet's syndrome [7]

Rheumatology

Volumn 46, Issue 7, 2007, Pages 1213-1214

  Seyahi, Emire ^a,b   Hamuryudan, V ^a   Hatemi, G ^a   Melikoglu, M ^a   Celik, S ^a   Fresko, I ^a   Yurdakul, S ^a   Yazici, H ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; INFLIXIMAB; METHYLPREDNISOLONE; PREDNISOLONE;

ABDOMINAL SWELLING; ADOLESCENT; ADULT; ASCITES; BEHCET DISEASE; BOLUS INJECTION; BRACHIOCEPHALIC VEIN; BUDD CHIARI SYNDROME; CASE REPORT; COMA; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DIPLOPIA; DISEASE COURSE; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DRUG INDUCED HEADACHE; HEMOPTYSIS; HEPATIC ENCEPHALOPATHY; HEPATOSPLENOMEGALY; HUMAN; INFERIOR CAVA VEIN; LETTER; LIVER FAILURE; LOBECTOMY; MALE; PAPILLEDEMA; PRIORITY JOURNAL; PULMONARY ARTERY ANEURYSM; SCHOOL CHILD; THROMBOSIS;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; BEHCET SYNDROME; CHILD; HEPATIC VEIN THROMBOSIS; HUMANS; MALE;

EID: 34447308770     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem103     Document Type: Letter

References (10)

1. Kural-Seyahi E, Fresko I, Seyahi N et al. The long-term mortality and morbidity of Behçet syndrome: A 2 decade outcome survey of 387 patients followed at a dedicated clinic. Medicine 2003;82;60-76.
2. Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M. Budd-Chiari síndrome: A common complication of Behçet's disease. Am J Gastroenterol 1997;92:858-62.
3. Olliff SP. Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome. Eur J Gastroenterol Hepatol 2006;18:1151-4.
4. Tuzun Y, Altac M, Yazici H et al. Nonspecific skin hyperreactivity in Behçet's disease. Haematologica 1980;65:395-8.
5. Kingston M, Ratcliffe JR, Alltree M, Merendino KA. Aneurysm after arterial puncture in Behçet's disease. Br Med J 1979;1:1766-7.
6. Sfikakis PP. Behçet's disease: A new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 2002;61(Suppl. 2):iI51-3.
7. Baki K, Villiger PM, Jenni D, Meyer T, Beer JH. Behçet's disease with life-threatening hemoptoe and pulmonary aneurysms: Complete remission after Infliximab treatment. Ann Rheum Dis 2006;65:1531-2.
8. Yee AM, Pochapin MB. Treatment of complicated sarcoidosis with Infliximab anti-tumour necrosis factor-alpha therapy. Ann Intern Med 2001;135: 27-31.
9. Puli SR, Benage DD. Retinal vein thrombosis after Infliximab (Remicade) treatment for Crohn's disease. Am J Gastroenterol 2003;98:939-40.
10. Grange L, Nissen MJ, Garambois K et al. Infliximab induced cerebral thrombophlebitis. Rheumatology 2005;44:260-1.